Natera Inc. and Neogenomics Laboratories Inc. announced a partial and confidential settlement on Friday, resolving aspects of their legal dispute surrounding the intellectual property related to a DNA test developed by Natera for cancer detection. Additional details on the settlement and the broader implications for the biotech patents landscape can be found here.